Higher Plasma Soluble TREM2 Correlates with Reduced Cerebral Tau Accumulation in Alzheimer’s Disease

The authors collected 318 Chinese older adults with Aβ PET and plasma biomarker measures, including soluble triggering receptor expressed on myeloid cell 2 (TREM2) and glial fibrillary acidic protein, a proxy for astrocyte reactivity.